跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PREVYMIS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PREVYMIS
Authorized
STANDARD
PREVYMIS
Merck Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
26af12af363e3703
Company
Merck Canada Inc
Type
Standard
Approval Details
Approval Id
26af12af363e3703
Drug Approval Canada Name
PREVYMIS
Product Name
PREVYMIS
Status
Marketed
Status Date
2017-12-20
Original Market Date
2017-12-20
Din
02469367
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:18.08.08
Atc Original
J05AX18 LETERMOVIR
Atc Name
j 05 ax 18
Aig Number
0159630001
Company Name
Merck Canada Inc
Company Address
16750 Route Transcanadienne, Kirkland, Quebec, Canada, H9H 4M7
Active Ingredients
LETERMOVIR
20 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
26af12af363e3703
Type
Standard
Back to Health Canada Approvals